Literature DB >> 11027184

293SF metabolic flux analysis during cell growth and infection with an adenoviral vector.

I Nadeau1, D Jacob, M Perrier, A Kamen.   

Abstract

Metabolic flux quantification of cell culture is becoming a crucial means to improve cell growth as well as protein and vector productions. The technique allows rapid determination of cell culture status, thus providing a tool for further feeding improvements. Herein, we report on key results of a metabolic investigation using 293 cells adapted to suspension and serum-free medium (293SF) during growth and infection with an adenoviral vector encoding the green fluorescence protein (GFP). The model developed contains 35 fluxes, which include the main fluxes of glycolysis, glutaminolysis, and amino acids pathways. It requires specific consumption and production rate measurements of amino acids, glucose, lactate, NH(3), and O(2), as well as DNA and total proteins biosynthesis rate measurements. Also, it was found that extracellular protein concentration measurement is important for flux calculation accuracy. With this model, we are able to describe the 293SF cell metabolism, grown under different culture conditions in a 3-L controlled bioreactor for batch and fed-batch with low glucose. The metabolism is also investigated during infection under two different feeding strategies: a fed-batch starting at the end of the growth phase and extending during infection without medium change and a fed-batch after infection following medium renewal. Differences in metabolism are observed between growth and infection, as well as between the different feeding strategies, thus providing a better understanding of the general metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027184     DOI: 10.1021/bp000098l

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

2.  Reduction of proteinuria through podocyte alkalinization.

Authors:  Mehmet M Altintas; Kumiko Moriwaki; Changli Wei; Clemens C Möller; Jan Flesche; Jing Li; Suma Yaddanapudi; Mohd Hafeez Faridi; Markus Gödel; Tobias B Huber; Richard A Preston; Jean X Jiang; Dontscho Kerjaschki; Sanja Sever; Jochen Reiser
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

Review 3.  Advanced stoichiometric analysis of metabolic networks of mammalian systems.

Authors:  Mehmet A Orman; Francois Berthiaume; Ioannis P Androulakis; Marianthi G Ierapetritou
Journal:  Crit Rev Biomed Eng       Date:  2011

4.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

5.  Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells.

Authors:  Vincent Gueret; Juan A Negrete-Virgen; Andrew Lyddiatt; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

6.  Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.

Authors:  Emma Petiot; Danielle Jacob; Stephane Lanthier; Verena Lohr; Sven Ansorge; Amine A Kamen
Journal:  BMC Biotechnol       Date:  2011-09-01       Impact factor: 2.563

7.  The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis.

Authors:  Verena Lohr; Oliver Hädicke; Yvonne Genzel; Ingo Jordan; Heino Büntemeyer; Steffen Klamt; Udo Reichl
Journal:  BMC Biotechnol       Date:  2014-07-30       Impact factor: 2.563

8.  Metabolic flux profiling of MDCK cells during growth and canine adenovirus vector production.

Authors:  Nuno Carinhas; Daniel A M Pais; Alexey Koshkin; Paulo Fernandes; Ana S Coroadinha; Manuel J T Carrondo; Paula M Alves; Ana P Teixeira
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.